CAS 1809427-19-7

N-((1R,2R,3S)-2-Hydroxy-3-(10H-phenoxazin-10-yl)cyclohexyl)-4-(trifluoromethoxy)benzenesulfonamide

CAS: 1809427-19-7

Formel: C₂₅H₂₃F₃N₂O₅S

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 520.5207

Ref: IN-DA01V45B

N-((1R,2R,3S)-2-Hydroxy-3-(10H-phenoxazin-10-yl)cyclohexyl)-4-(trifluoromethoxy)benzenesulfonamide

CAS: 1809427-19-7

N-((1R,2R,3S)-2-Hydroxy-3-(10H-phenoxazin-10-yl)cyclohexyl)-4-(trifluoromethoxy)benzenesulfonamide

Reinheit: 99%

Molekulargewicht: 520.53g/mol

Ref: 54-PC1007955

DT-061(SMAP)

CAS: 1809427-19-7

DT-061 is a novel antimicrobial peptide that contains six cysteine residues and one lysine residue. DT-061 inhibits bacterial growth by binding to the cell membrane and forming pores, which leads to increased permeability, leakage of intracellular contents, and finally cell death. DT-061 has been shown to be effective against tumor xenografts in mice. This drug also inhibits the expression of target genes in prostate cancer cells when used at low concentrations.

Formel: C₂₅H₂₃F₃N₂O₅S

Reinheit: Min. 95%

Molekulargewicht: 520.52 g/mol

Ref: 3D-JXC42719

DT-061

CAS: 1809427-19-7

DT-061 is an orally bioavailable protein phosphatase 2A (PP2A) activator. It could be applied in the therapy of KRAS-mutant and MYC-driven tumorigenesis.

Formel: C₂₅H₂₃F₃N₂O₅S

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 520.52

Ref: TM-T10060L